These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 28819741)

  • 1. Signaling Pathways as Potential Therapeutic Targets in Hepatocarcinogenesis.
    Yılmaz Y; Güneş A; Topel H; Atabey N
    J Gastrointest Cancer; 2017 Sep; 48(3):225-237. PubMed ID: 28819741
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies?
    Boye A; Zou YH; Yang Y
    World J Gastroenterol; 2016 Jan; 22(1):50-71. PubMed ID: 26755860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signaling networks in human hepatocarcinogenesis--novel aspects and therapeutic options.
    Breuhahn K; Schirmacher P
    Prog Mol Biol Transl Sci; 2010; 97():251-77. PubMed ID: 21074736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Panax ginseng exerts antiproliferative effects on rat hepatocarcinogenesis.
    Kim H; Lee HJ; Kim DJ; Kim TM; Moon HS; Choi H
    Nutr Res; 2013 Sep; 33(9):753-60. PubMed ID: 24034575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic alterations in liver carcinogenesis: implications for new preventive and therapeutic strategies.
    Feo F; Pascale RM; Simile MM; De Miglio MR; Muroni MR; Calvisi D
    Crit Rev Oncog; 2000; 11(1):19-62. PubMed ID: 10795626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways.
    Koike K
    J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S108-11. PubMed ID: 17567457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposite roles of cannabinoid receptors 1 and 2 in hepatocarcinogenesis.
    Suk KT; Mederacke I; Gwak GY; Cho SW; Adeyemi A; Friedman R; Schwabe RF
    Gut; 2016 Oct; 65(10):1721-32. PubMed ID: 27196571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy-dependent generation of Axin2+ cancer stem-like cells promotes hepatocarcinogenesis in liver cirrhosis.
    Li J; Hu SB; Wang LY; Zhang X; Zhou X; Yang B; Li JH; Xiong J; Liu N; Li Y; Wu YZ; Zheng QC
    Oncogene; 2017 Nov; 36(48):6725-6737. PubMed ID: 28783177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced nuclear factor-kappa B-associated Wnt-1 expression in hepatitis B- and C-related hepatocarcinogenesis: identification by functional proteomics.
    Lee TH; Tai DI; Cheng CJ; Sun CS; Lin CY; Sheu MJ; Lee WP; Peng CY; Wang AH; Tsai SL
    J Biomed Sci; 2006 Jan; 13(1):27-39. PubMed ID: 16228287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs.
    Pez F; Lopez A; Kim M; Wands JR; Caron de Fromentel C; Merle P
    J Hepatol; 2013 Nov; 59(5):1107-17. PubMed ID: 23835194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2 in hepatocellular carcinoma.
    Wu T
    Cancer Treat Rev; 2006 Feb; 32(1):28-44. PubMed ID: 16337744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different pathways of constitutive androstane receptor-mediated liver hypertrophy and hepatocarcinogenesis in mice treated with piperonyl butoxide or decabromodiphenyl ether.
    Sakamoto Y; Inoue K; Takahashi M; Taketa Y; Kodama Y; Nemoto K; Degawa M; Gamou T; Ozawa S; Nishikawa A; Yoshida M
    Toxicol Pathol; 2013; 41(8):1078-92. PubMed ID: 23531792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical regulators of Wnt/β-catenin signaling as potential therapeutic targets in Hepatocellular Carcinoma.
    Chen J; Rajasekaran M; Hui KM
    Exp Biol Med (Maywood); 2017 Jun; 242(11):1142-1149. PubMed ID: 28429652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Amino-3-methylimidazo[4,5-f]quinoline (IQ) promotes mouse hepatocarcinogenesis by activating transforming growth factor-β and Wnt/β-catenin signaling pathways.
    Xie XL; Wei M; Kakehashi A; Yamano S; Tajiri M; Wanibuchi H
    Toxicol Sci; 2012 Feb; 125(2):392-400. PubMed ID: 22094457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis.
    Cigliano A; Pilo MG; Li L; Latte G; Szydlowska M; Simile MM; Paliogiannis P; Che L; Pes GM; Palmieri G; Sini MC; Cossu A; Porcu A; Vidili G; Seddaiu MA; Pascale RM; Ribback S; Dombrowski F; Chen X; Calvisi DF
    Oncotarget; 2017 Oct; 8(53):90638-90650. PubMed ID: 29207593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell death and hepatocarcinogenesis: Dysregulation of apoptosis signaling pathways.
    Schattenberg JM; Schuchmann M; Galle PR
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():213-9. PubMed ID: 21199533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Ras/MAPK pathway and hepatocarcinoma: pathogenesis and therapeutic implications.
    Delire B; Stärkel P
    Eur J Clin Invest; 2015 Jun; 45(6):609-23. PubMed ID: 25832714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orally administered lycopene attenuates diethylnitrosamine-induced hepatocarcinogenesis in rats by modulating Nrf-2/HO-1 and Akt/mTOR pathways.
    Sahin K; Orhan C; Tuzcu M; Sahin N; Ali S; Bahcecioglu IH; Guler O; Ozercan I; Ilhan N; Kucuk O
    Nutr Cancer; 2014; 66(4):590-8. PubMed ID: 24660901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin delays AKT/c-Met-driven hepatocarcinogenesis by regulating signaling pathways for de novo lipogenesis and ATP generation.
    Zhang C; Hu J; Sheng L; Yuan M; Wu Y; Chen L; Zheng G; Qiu Z
    Toxicol Appl Pharmacol; 2019 Feb; 365():51-60. PubMed ID: 30625338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-ionone inhibits nonalcoholic fatty liver disease and its association with hepatocarcinogenesis in male Wistar rats.
    Miranda MLP; Furtado KS; de Oliveira Andrade F; Heidor R; da Cruz RS; Nogueira MS; de Castro IA; Purgatto E; Barbisan LF; Moreno FS
    Chem Biol Interact; 2019 Aug; 308():377-384. PubMed ID: 31150631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.